SNCA and Alzheimer disease: In this context, substantial efforts have carved out the primary affected central nervous system (CNS) cell types and key risk genes driving the underlying pathology, e.g., APOE and TREM2 in microglia for AD, or alpha-synuclein (SNCA) contained in Lewy-bodies in dopaminergic neurons for PD9–13.